Aspiriant LLC’s Consolidated Edison ED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Buy
+1,915
New +$208K 0.01% 376
2017
Q4
Sell
-2,602
Closed -$210K 107
2017
Q3
$210K Buy
2,602
+1
+0% +$83 0.02% 192
2017
Q2
$210K Sell
2,601
-1,727
-40% -$140K 0.02% 196
2017
Q1
$336K Buy
4,328
+557
+15% +$41.9K 0.03% 168
2016
Q4
$278K Sell
3,771
-4,021
-52% -$291K 0.03% 165
2016
Q3
$587K Buy
7,792
+958
+14% +$74.4K 0.06% 129
2016
Q2
$550K Buy
+6,834
New +$514K 0.05% 133

Other funds holding ED

Aspiriant LLC's ED Position: Q2 2026 in Review

Aspiriant LLC opened a new position in Consolidated Edison (ED) in Q2 2026: 1,915 shares worth $212K. The stake represents 0.01% of the portfolio and ranks #376 among its holdings. This is a return to the name: Aspiriant LLC previously reported a position in ED as recently as Q3 2017.

Aspiriant LLC first reported a position in ED in Q2 2016 and has held it in 7 quarters since. The position peaked at $587K in Q3 2016. 1,430 funds tracked by Wall St. Rank hold ED as of Q2 2026.

  • Aspiriant LLC held 1,915 shares of Consolidated Edison worth $212K as of Q2 2026.
  • Consolidated Edison was a new Aspiriant LLC position in Q2 2026.
  • Consolidated Edison made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #376 holding.
  • Aspiriant LLC first reported a position in Consolidated Edison in Q2 2016 and has held it in 7 quarters since.
  • Aspiriant LLC's Consolidated Edison position peaked at $587K in Q3 2016.
  • 1,430 funds tracked by Wall St. Rank held Consolidated Edison as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.